Emmanuelle SAMALIN, MD

Trials

Studies that name Emmanuelle SAMALIN, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:52 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06245356 · Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

  UNICANCER · recruiting · Metastatic Colorectal Cancer, Metastatic Gastroesophageal Adenocarcinoma, DPD Deficiency · principal investigator
• N/A
  NCT04186117 · Development of Clinical and Biological Database in Colorectal Cancer

  Institut du Cancer de Montpellier - Val d'Aurelle · completed · Metastatic Colon Cancer · study chair
• N/A
  NCT03914170 · Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer

  Institut du Cancer de Montpellier - Val d'Aurelle · completed · Colorectal Cancer · principal investigator
• Ph3
  NCT03829462 · Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients

  Institut du Cancer de Montpellier - Val d'Aurelle · active not recruiting · Metastatic Colorectal Cancer (mCRC) · study chair
• Ph2
  NCT01715441 · Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

  Institut du Cancer de Montpellier - Val d'Aurelle · completed · Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.